Draft Genome Sequence of a Clinical Isolate of Serratia marcescens, Strain AH0650_Sm1

Yu Wan; Claire L Gorrie; Adam Jenney; Mirjana Mirceta; Kathryn E Holt

doi:10.1128/genomeA.01007-15

Draft Genome Sequence of a Clinical Isolate of Serratia marcescens, Strain AH0650_Sm1

Genome Announc. 2015 Sep 3;3(5):e01007-15. doi: 10.1128/genomeA.01007-15.

Authors

Yu Wan¹, Claire L Gorrie², Adam Jenney³, Mirjana Mirceta³, Kathryn E Holt¹

Affiliations

¹ Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria, Australia Centre for Systems Genomics, University of Melbourne, Victoria, Australia wanyuac@gmail.com kholt@unimelb.edu.au.
² Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria, Australia Centre for Systems Genomics, University of Melbourne, Victoria, Australia Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, Australia.
³ Department of Infectious Diseases and Microbiology Unit, The Alfred Hospital, Victoria, Australia.

Abstract

Serratia marcescens strain AH0650_Sm1 is a clinical multidrug-resistant isolate from Australia. Here, we report its annotated draft genome comprising 20 contigs. We identified chromosomal antimicrobial resistance genes including a tet(41) variant, an aac(6')-Ic variant, ampC, a metallo-beta-lactamase, and several putative multidrug efflux pumps, as well as a novel prophage.